TWIICE One Exoskeleton is a Step Towards Independence

November 6, 2018 Vijay Soni 0

TWIICE One Exoskeleton is a Step Towards Independence By: Anne-Muriel Brouet The new version of the TWIICE walking-assistance system is not only lighter, more comfortable and more powerful, but patients can also put it on and use it themselves – giving them greater independence. It has been tested by handcycling champion [..]

Chemical Synthesis Could Produce More Potent Antibiotics

November 5, 2018 Vijay Soni 0

Chemical Synthesis Could Produce More Potent Antibiotics By: Anne Trafton | MIT News Office Using a novel type of chemical reaction, MIT researchers have shown that they can modify antibiotics in a way that could potentially make them more effective against drug-resistant infections. By chemically linking the antibiotic vancomycin to [..]

Sandoz Receives FDA Approval for Biosimilar HyrimozTM

October 31, 2018 Vijay Soni 0

Sandoz Receives FDA Approval for Biosimilar HyrimozTM By: Novartis News Sandoz, a Novartis division and the pioneer and global leader in biosimilars, today announced that the US Food and Drug Administration (FDA) approved its biosimilar, HyrimozTM (adalimumab-adaz). The FDA granted approval for the treatment of rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA) in patients [..]

New CRISPR Tool Opens Up More of The Genome For Editing

October 26, 2018 Vijay Soni 0

New CRISPR Tool Opens Up More of The Genome For Editing By: Helen Knight | MIT News correspondent The genome editing system CRISPR has become a hugely important tool in medical research, and could ultimately have a significant impact in fields such as agriculture, bioenergy, and food security. The targeting system [..]

Probiotics And Antibiotics Create a Killer Combination

October 22, 2018 Vijay Soni 0

Probiotics And Antibiotics Create a Killer Combination By: Anne Trafton | MIT News Office In the fight against drug-resistant bacteria, MIT researchers have enlisted the help of beneficial bacteria known as probiotics. In a new study, the researchers showed that by delivering a combination of antibiotic drugs and probiotics, they could [..]

New, Highly Stable Catalyst May Help Turn Water Into Fuel

September 30, 2018 Vijay Soni 0

New, Highly Stable Catalyst May Help Turn Water Into Fuel By: Lois Yoksoulian |Physical Sciences Editor Breaking the bonds between oxygen and hydrogen in water could be a key to the creation of hydrogen in a sustainable manner, but finding an economically viable technique for this has proved difficult. Researchers report [..]

Perovskite Solar Cells Leap Towards Commercialization

September 30, 2018 Vijay Soni 0

Perovskite Solar Cells Leap Towards Commercialization By : Ipsita Herlekar |OSIT News Solar energy has long been considered the most sustainable option for replacing our dependence on fossil fuels, but technologies for converting solar energy into electricity must be both efficient and inexpensive. Scientists from the Energy Materials and Surface Sciences Unit at [..]

Libtayo® Received FDA Aproval As First And Only Treatment For Second Most Common Skin Cancer

September 30, 2018 Vijay Soni 0

Libtayo® Received FDA Aproval As First And Only Treatment For Second Most Common Skin Cancer Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi announced that the U.S. Food and Drug Administration (FDA) has approved Libtayo® (cemiplimab-rwlc) for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not candidates for curative surgery [..]

FDA Approved the First and Only Therapy for the Treatment of Mycobacterium Avium Complex (MAC) Lung Disease

September 30, 2018 Vijay Soni 0

FDA Approved the First and Only Therapy for the Treatment of Mycobacterium Avium Complex (MAC) Lung Disease Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of ARIKAYCE® (amikacin liposome inhalation suspension) for the [..]

New Battery Gobbles Up Carbon Dioxide

September 30, 2018 Vijay Soni 0

New Battery Gobbles Up Carbon Dioxide By: David L. Chandler | MIT News Office A new type of battery developed by researchers at MIT could be made partly from carbon dioxide captured from power plants. Rather than attempting to convert carbon dioxide to specialized chemicals using metal catalysts, which is currently [..]

Maze Solver Robotics Workshop, Gwalior-India | Scipreneur

September 8, 2018 Vijay Soni 0

MAZE SOLVER Robotics Workshop, Gwalior-India | Scipreneur 15-16th September, 2018 Venue: Madhav Institute of Technology and Science, Gwalior, MP, India The best way to predict the future is to invent it! IETE students’ forum MITS is back with a workshop on ‘MAZE SOLVER ROBOT’ Powered by Scipreneur Pvt Limied. It is [..]

Nanotubes Change The Shape of Water

September 1, 2018 Vijay Soni 0

Nanotubes Change The Shape of Water By: Rice University News First, according to Rice University engineers, get a nanotube hole. Then insert water. If the nanotube is just the right width, the water molecules will align into a square rod. Rice materials scientist Rouzbeh Shahsavari and his team used molecular models to [..]

Relationship Between Intelligence and Creativity

August 26, 2018 Vijay Soni 0

Relationship Between Intelligence and Creativity By: Vijay Soni, PhD| Founder Scipreneur and TOC Intelligence is the ability to acquire and utilize knowledge, whereas creativity is the act of having original and valuable thoughts. It’s immediately clear see how the two are linked in utility, though not so much in substance. [..]

Shape-Shifting Material Can Morph, Reverse Itself Using Heat, Light

August 26, 2018 Vijay Soni 0

Shape-Shifting Material Can Morph, Reverse Itself Using Heat, Light By: University of Colorado at Boulder A new material developed by CU Boulder engineers can transform into complex, pre-programmed shapes via light and temperature stimuli, allowing a literal square peg to morph and fit into a round hole before fully reverting to [..]

New Antibiotic Candidates Discovered by MIT Scientists

August 23, 2018 Vijay Soni 0

New Antibiotic Candidates Discovered by MIT Scientists By: Anne Trafton | MIT News Office The human body produces many antimicrobial peptides that help the immune system fend off infection. Scientists hoping to harness these peptides as potential antibiotics have now discovered that other peptides in the human body can also [..]

Picture This: Camera With No Lens

August 22, 2018 Vijay Soni 0

Picture This: Camera With No Lens By: University of Uta News In the future, your car windshield could become a giant camera sensing objects on the road. Or each window in a home could be turned into a security camera. University of Utah electrical and computer engineers have discovered a [..]

Novel Optics for Ultrafast Cameras

August 16, 2018 Vijay Soni 0

Novel Optics for Ultrafast Cameras By: Rob Matheson | MIT News Office MIT researchers have developed novel photography optics that capture images based on the timing of reflecting light inside the optics, instead of the traditional approach that relies on the arrangement of optical components. These new principles, the researchers [..]

Theory of Creativity Challenge| Last Date 10th Sept 2018

August 15, 2018 Vijay Soni 0

Theory of Creativity Challenge: August 2018 Last Date is Extended to September 10th 2018 What is Theory of Creativity (TOC) August 2018 Challenge? With “TOC Aug 2018 Challenge”  we would like to stimulate the thought process of young and creative mind and enable them to understand the upcoming challenges of [..]

Creativity and Innovation

August 15, 2018 Vijay Soni 0

Creativity and Innovation By: Theory of Creativity | Scipreneur Creativity is the act of turning new and imaginative ideas into reality. Creativity is characterised by the ability to perceive the world in new ways, to find hidden patterns, to make connections between seemingly unrelated phenomena, and to generate solutions. Creativity [..]

FDA Approved First siRNA Based New Class of Drug for a Rare Genetic Disease

August 10, 2018 Vijay Soni 0

FDA Approved First siRNA Based New Class of Drug for a Rare Genetic Disease By: Alnylam News Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that the United States Food and Drug Administration (FDA) approved ONPATTRO™ (patisiran) lipid complex injection, a first-of-its-kind RNA interference (RNAi) therapeutic, for the treatment [..]

New Era for Migraine Patients: EU Approved Aimovig® of Novartis

August 1, 2018 Vijay Soni 0

New Era for Migraine Patients: EU Approved Aimovig® of Novartis   Novartis announced that the European Commission (EC) approved Aimovig® (erenumab) for the prevention of migraine in adults experiencing four or more migraine days per month. Aimovig is the first and only treatment specifically designed for migraine prevention to be approved [..]